Clinical Trial

Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants

Name: Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants — clinical trial record (NCT06878742)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NeoCirc-002

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Single centre, dose finding trial to establish the minimum effective dose of dobutamine required to treat hemodynamic insufficiency, defined as low superior vena cava (SVC) flow, in infants below 33 weeks' gestation during transitional circulation (first 72 hours from birth).

Trial Details

NCT Number	NCT06878742
Lead Sponsor	Instituto de Investigación Hospital Universitario La Paz
Conditions	Infant, Premature, Diseases, Circulatory and Respiratory Physiological Phenomena
Enrollment	30 participants
Start Date	2024-06-24
Primary Completion	2029-06 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2025-03-17